Search results
Study: Older Adults With Aggressive Blood Cancer A | Newswise
Newswise· 22 hours agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Obituary - Steven Michael Kakuska
Fontana Herald News· 2 hours agoSteven Michael Kakuska’s battle with acute myeloid leukemia ended on Saturday, March 27, when he passed away at Kaiser Hospital in Fontana ...
Exxon ordered to pay $725M to mechanic who claimed toxic chemicals caused his cancer
New York Post· 6 hours agoThe 67-year-old former mechanic said in his 2020 lawsuit that he used petroleum products to clean...
Jury Says Exxon Mobil Must Pay $725 Million to Former Mechanic Who Developed Cancer
The Wall Street Journal· 7 hours agoA Pennsylvania jury found Exxon Mobil liable for about $725 million in compensatory damages to a...
Philadelphia jury awards former mechanic $725.5M in Exxon Mobil case
Philly.com· 11 hours agoA Philadelphia jury sided against Exxon Mobil Corp. and awarded $725.5 million on Thursday to a...
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 6 days agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 2 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
Morningstar· 11 hours agoA Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum ...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 4 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
GlycoMimetics downgraded after Phase 3 trial fails to meet endpoint By Investing.com
Investing.com· 4 days agoGlycoMimetics' uproleselan, a drug candidate for treating relapsed or refractory acute myeloid ...